| Website | proteostasis.com |
| Phone | 617-225-0096 |
| Employees |
| Series A, 8/08 HealthCare Ventures Fidelity Biosciences New Enterprise Associates Genzyme Ventures Novartis Ventures | $45M |
Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body’s natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer’s Disease and Huntington’s Disease.
